Australia markets open in 3 hours 27 minutes

Imagion Biosystems Limited (IBX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0850-0.0010 (-1.16%)
At close: 04:10PM AEST

Imagion Biosystems Limited

5601 Oberlin Drive
Suite 100
San Diego, CA 92121
United States
855 564 5264

IndustryDiagnostics & Research
Full-time employees


Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers, as well as in preclinical stage to treat prostate, ovarian, brain, and pancreatic cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to detect cancer. The company has a collaborative research program with Patrys Limited and The University of Sydney. Imagion Biosystems Limited was incorporated in 2016 and is based in San Diego, California.

Corporate governance

Imagion Biosystems Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.